Literature DB >> 7022718

Immunopathogenesis of the extrahepatic manifestations of hepatitis B virus infection.

J L Dienstag.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7022718     DOI: 10.1007/bf01951493

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  90 in total

1.  Arthritis in viral hepatitis. Report of two cases and review of the literature.

Authors:  G S Alarcon; A S Townes
Journal:  Johns Hopkins Med J       Date:  1973-01

2.  Infusion of hepatitis-B antibody in antigen-positive active chronic hepatitis.

Authors:  W D Reed; A L Eddleston; H Cullens; R Williams; A J Zuckerman; D K Peters; D G Williams; W A Maycock
Journal:  Lancet       Date:  1973-12-15       Impact factor: 79.321

3.  Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane.

Authors:  B Combes; J Shorey; A Barrera; P Stastny; E H Eigenbrodt; A R Hull; N W Carter
Journal:  Lancet       Date:  1971-07-31       Impact factor: 79.321

4.  Pathogenesis of renal disease associated with viral hepatitis.

Authors:  M R Knieser; E H Jenis; D T Lowenthal; W H Bancroft; W Burns; R Shalhoub
Journal:  Arch Pathol       Date:  1974-04

5.  HBs Ag in superficial artery of patient with polymyalgia rheumatica.

Authors:  B Plouvier; P Wattre; B Devulder
Journal:  Lancet       Date:  1978-04-29       Impact factor: 79.321

6.  Chronic membranous glomerulonephritis caused by hepatitis B antigen-antibody immune complexes.

Authors:  P F Kohler; R E Cronin; W S Hammond; D Olin; R I Carr
Journal:  Ann Intern Med       Date:  1974-10       Impact factor: 25.391

7.  HBsAg immune complexes in the course of infection with hepatitis B virus.

Authors:  K Madaliński; I Bragiel
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

8.  A complement-fixation test for measuring Australia antigen and antibody.

Authors:  R H Purcell; P V Holland; J H Walsh; D C Wong; A G Morrow; R M Chanock
Journal:  J Infect Dis       Date:  1969-09       Impact factor: 5.226

9.  Hepatitis-B antibody in polymyalgia Rheumatica.

Authors:  P A Bacon; S M Doherty; A J Zuckerman
Journal:  Lancet       Date:  1975-09-13       Impact factor: 79.321

10.  Complement metabolism in chronic liver disease: catabolism of C1q in chronic active liver disease and primary biliary cirrhosis.

Authors:  B J Potter; E Elias; H C Thomas; S Sherlock
Journal:  Gastroenterology       Date:  1980-05       Impact factor: 22.682

View more
  6 in total

1.  Detection of HBsAg from circulating immune complex: clinical significance in diagnosis of hepatitis B glomerulonephritis in children.

Authors:  X M Li; Y Q Wang; M T Song
Journal:  Acta Acad Med Wuhan       Date:  1983

2.  Immunopathology of glomerulonephritis associated with chronic woodchuck hepatitis virus infection in woodchucks (Marmota monax).

Authors:  D N Peters; H Steinberg; W I Anderson; W E Hornbuckle; P J Cote; J L Gerin; R M Lewis; B C Tennant
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

Review 3.  Molecular mechanisms underlying occult hepatitis B virus infection.

Authors:  Jasmine Samal; Manish Kandpal; Perumal Vivekanandan
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

Review 4.  Epidemiology and prevention of hepatitis B virus infection.

Authors:  So Young Kwon; Chang Hong Lee
Journal:  Korean J Hepatol       Date:  2011-06

5.  Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices.

Authors:  Sarah Schillie; Claudia Vellozzi; Arthur Reingold; Aaron Harris; Penina Haber; John W Ward; Noele P Nelson
Journal:  MMWR Recomm Rep       Date:  2018-01-12

6.  Insights into the genetic diversity, recombination, and systemic infections with evidence of intracellular maturation of hepadnavirus in cats.

Authors:  Chutchai Piewbang; Sabrina Wahyu Wardhani; Surangkanang Chaiyasak; Jakarwan Yostawonkul; Poowadon Chai-In; Suwimon Boonrungsiman; Tanit Kasantikul; Somporn Techangamsuwan
Journal:  PLoS One       Date:  2020-10-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.